Literature DB >> 20005600

MRI-based volumetric measurement of the substantia innominata in amnestic MCI and mild AD.

S George1, E J Mufson, S Leurgans, R C Shah, C Ferrari, L deToledo-Morrell.   

Abstract

The substantia innominata (SI) contains the nucleus basalis of Meynert, which provides the major cholinergic innervation to the entire cortical mantel and the amygdala; degeneration of nucleus basalis neurons correlates with cognitive decline in Alzheimer's disease (AD). However, whether SI atrophy occurs in individuals with amnestic mild cognitive impairment (aMCI) has not been examined thoroughly in vivo. In the present study, we developed a new protocol to measure volumetric changes in the SI from magnetic resonance imaging (MRI) scans. Participants consisted of 27 elderly controls with no cognitive impairment (NCI); 33 individuals with aMCI; and 19 patients with mild AD. SI volumes were traced on three consecutive gapless 1mm thick coronal slices. Results showed that SI volume was significantly reduced in the mild AD group compared to both NCI and aMCI participants; however, the NCI and aMCI groups did not differ from each other. Furthermore, a decrease in SI volume was related to impaired performance on declarative memory tasks even when attention was controlled.
Copyright © 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20005600      PMCID: PMC2888825          DOI: 10.1016/j.neurobiolaging.2009.11.006

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  60 in total

1.  Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment.

Authors:  J H Kordower; Y Chu; G T Stebbins; S T DeKosky; E J Cochran; D Bennett; E J Mufson
Journal:  Ann Neurol       Date:  2001-02       Impact factor: 10.422

2.  MRI measures of entorhinal cortex vs hippocampus in preclinical AD.

Authors:  R J Killiany; B T Hyman; T Gomez-Isla; M B Moss; R Kikinis; F Jolesz; R Tanzi; K Jones; M S Albert
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

3.  Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert.

Authors:  I Sassin; C Schultz; D R Thal; U Rüb; K Arai; E Braak; H Braak
Journal:  Acta Neuropathol       Date:  2000-09       Impact factor: 17.088

4.  Atrophy of the substantia innominata on magnetic resonance imaging and response to donepezil treatment in Alzheimer's disease.

Authors:  Haruo Hanyu; Yuriko Tanaka; Hirofumi Sakurai; Masaru Takasaki; Kimihiko Abe
Journal:  Neurosci Lett       Date:  2002-02-08       Impact factor: 3.046

5.  MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia.

Authors:  Haruo Hanyu; Tetsuichi Asano; Hirofumi Sakurai; Yuriko Tanaka; Masaru Takasaki; Kimihiko Abe
Journal:  AJNR Am J Neuroradiol       Date:  2002-01       Impact factor: 3.825

6.  Learning impairments following injection of a selective cholinergic immunotoxin, ME20.4 IgG-saporin, into the basal nucleus of Meynert in monkeys.

Authors:  A Fine; C Hoyle; C J Maclean; T L Levatte; H F Baker; R M Ridley
Journal:  Neuroscience       Date:  1997-11       Impact factor: 3.590

Review 7.  From healthy aging to early Alzheimer's disease: in vivo detection of entorhinal cortex atrophy.

Authors:  L de Toledo-Morrell; I Goncharova; B Dickerson; R S Wilson; D A Bennett
Journal:  Ann N Y Acad Sci       Date:  2000-06       Impact factor: 5.691

8.  Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up.

Authors:  D P Devanand; K S Michaels-Marston; X Liu; G H Pelton; M Padilla; K Marder; K Bell; Y Stern; R Mayeux
Journal:  Am J Psychiatry       Date:  2000-09       Impact factor: 18.112

9.  Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

Authors:  Steven T DeKosky; Milos D Ikonomovic; Scot D Styren; Laurel Beckett; Stephen Wisniewski; David A Bennett; Elizabeth J Cochran; Jeffrey H Kordower; Elliott J Mufson
Journal:  Ann Neurol       Date:  2002-02       Impact factor: 10.422

10.  Natural history of mild cognitive impairment in older persons.

Authors:  D A Bennett; R S Wilson; J A Schneider; D A Evans; L A Beckett; N T Aggarwal; L L Barnes; J H Fox; J Bach
Journal:  Neurology       Date:  2002-07-23       Impact factor: 9.910

View more
  20 in total

Review 1.  Mild cognitive impairment: pathology and mechanisms.

Authors:  Elliott J Mufson; Lester Binder; Scott E Counts; Steven T DeKosky; Leyla de Toledo-Morrell; Stephen D Ginsberg; Milos D Ikonomovic; Sylvia E Perez; Stephen W Scheff
Journal:  Acta Neuropathol       Date:  2011-11-19       Impact factor: 17.088

2.  Atrophy of the cholinergic Basal forebrain over the adult age range and in early stages of Alzheimer's disease.

Authors:  Michel Grothe; Helmut Heinsen; Stefan J Teipel
Journal:  Biol Psychiatry       Date:  2011-08-04       Impact factor: 13.382

3.  Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment.

Authors:  Michel J Grothe; Helmut Heinsen; Edson Amaro; Lea T Grinberg; Stefan J Teipel
Journal:  Cereb Cortex       Date:  2015-04-02       Impact factor: 5.357

Review 4.  Hippocampal plasticity during the progression of Alzheimer's disease.

Authors:  E J Mufson; L Mahady; D Waters; S E Counts; S E Perez; S T DeKosky; S D Ginsberg; M D Ikonomovic; S W Scheff; L I Binder
Journal:  Neuroscience       Date:  2015-03-12       Impact factor: 3.590

5.  Subregional basal forebrain atrophy in Alzheimer's disease: a multicenter study.

Authors:  Ingo Kilimann; Michel Grothe; Helmut Heinsen; Eduardo Joaquim Lopez Alho; Lea Grinberg; Edson Amaro; Gláucia Aparecida Bento Dos Santos; Rafael Emídio da Silva; Alex J Mitchell; Giovanni B Frisoni; Arun L W Bokde; Andreas Fellgiebel; Massimo Filippi; Harald Hampel; Stefan Klöppel; Stefan J Teipel
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

6.  Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects.

Authors:  Michel J Grothe; Michael Ewers; Bernd Krause; Helmut Heinsen; Stefan J Teipel
Journal:  Alzheimers Dement       Date:  2014-01-10       Impact factor: 21.566

7.  Neurological imaging: statistics behind the pictures.

Authors:  Ivo D Dinov
Journal:  Imaging Med       Date:  2011-08-01

8.  Are Linear Measurements of the Nucleus Basalis of Meynert Suitable as a Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer Disease?

Authors:  K D Jethwa; P Dhillon; D Meng; D P Auer
Journal:  AJNR Am J Neuroradiol       Date:  2019-11-14       Impact factor: 3.825

9.  New MRI Biomarkers Advance the Characterization of Parkinson Disease.

Authors:  David A Ziegler; Suzanne Corkin
Journal:  Eur Neurol Rev       Date:  2013

10.  Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease.

Authors:  Michel Grothe; Helmut Heinsen; Stefan Teipel
Journal:  Neurobiol Aging       Date:  2012-11-15       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.